[Exquisite sensitivity of TP53 mutant breast cancers to dose-dense chemotherapy]

Med Sci (Paris). 2007 Nov;23(11):1021-3. doi: 10.1051/medsci/200723111021.
[Article in French]
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / mortality
  • Female
  • Humans
  • Survival Analysis
  • Survivors
  • Treatment Outcome
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • Antineoplastic Agents
  • Tumor Suppressor Protein p53